TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

CRYODERM

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: US

Quick snapshot

CRYODERM

ST13

US500000076575932

Class

5

Filing

76575932

Registration

3303089

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

Attention: there is active risk

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

34

Latest update

10/25/2017

Classification

Registered

Trademark type

Word

Nice classes

5

Filing date

02/17/2004

Registration date

10/02/2007

Expiration date

-

Recommended action

Perform a full collision analysis and validate classes before any filing or trademark investment.

Next step

These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.

Complete case details

Structured fields from the responsible authority and the official record.

Status date

10/25/2017

Last transaction

10/25/2017

Responsible office

United States Patent and Trademark Office

Status code

800

Official register

Principal Register

Filing basis

Intent to use

First use anywhere

03/10/2004

First use in commerce

03/10/2004

Drawing code

4

Owner type

03

Owner location

Margate, FL, US

Examiner

DWYER, JOHN D

Law office

M70

Current location

GENERIC WEB UPDATE

Holders and representatives

Holders

AHC Ventures, Corp.
AHC Ventures, Corp.

Representatives

John Cyril Malloy, III MALLOY & MALLOY P.L.

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

analgesic pain reliever for topical application

Publications

History of USPTO decisions and trademark events.

34 publications found

NA89

NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED

10/25/2017

RNL1

REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)

10/25/2017

89AG

REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED

10/25/2017

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

10/25/2017

E89R

TEAS SECTION 8 & 9 RECEIVED

09/29/2017

NA85

NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - MAILED

10/07/2013

C15A

REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.

10/07/2013

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

10/07/2013

815F

REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED

10/02/2013

E815

TEAS SECTION 8 & 15 RECEIVED

10/02/2013

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

10/02/2013

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

10/02/2013

R.PR

REGISTERED-PRINCIPAL REGISTER

10/02/2007

REGV

LAW OFFICE REGISTRATION REVIEW COMPLETED

08/28/2007

ALIE

ASSIGNED TO LIE

08/28/2007

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

07/18/2007

SUPC

STATEMENT OF USE PROCESSING COMPLETE

07/18/2007

IUAF

USE AMENDMENT FILED

04/19/2007

EISU

TEAS STATEMENT OF USE RECEIVED

04/19/2007

NOAM

NOA MAILED - SOU REQUIRED FROM APPLICANT

11/07/2006

OP.T

OPPOSITION TERMINATED NO. 999999

09/22/2006

OP.D

OPPOSITION DISMISSED NO. 999999

09/22/2006

OP.I

OPPOSITION INSTITUTED NO. 999999

12/10/2004

OPPF

OPPOSITION PAPERS RECEIVED AT TTAB

12/09/2004

PUBO

PUBLISHED FOR OPPOSITION

11/09/2004

NPUB

NOTICE OF PUBLICATION

10/20/2004

PREV

LAW OFFICE PUBLICATION REVIEW COMPLETED

09/14/2004

ALIE

ASSIGNED TO LIE

09/10/2004

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

09/08/2004

XAEC

EXAMINER'S AMENDMENT ENTERED

09/07/2004

CNEA

EXAMINER'S AMENDMENT MAILED

09/07/2004

CNEA

EXAMINERS AMENDMENT -WRITTEN

09/07/2004

DOCK

ASSIGNED TO EXAMINER

09/07/2004

NWAP

NEW APPLICATION ENTERED

03/04/2004

Continuous trademark protection

Get notified about every new filing that threatens CRYODERM or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.